286 related articles for article (PubMed ID: 27943127)
1. Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.
Gonnelli S; Caffarelli C; Iolascon G; Bertoldo F; Letizia Mauro G; Patti A; Nuti R
Aging Clin Exp Res; 2017 Oct; 29(5):1031-1037. PubMed ID: 27943127
[TBL] [Abstract][Full Text] [Related]
2. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H
Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451
[TBL] [Abstract][Full Text] [Related]
3. Anti-Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture.
Wang PW; Li YZ; Zhuang HF; Yu HM; Cai SQ; Xu H; Chen ZH; Lin JK; Yao XD
Orthop Surg; 2019 Oct; 11(5):777-783. PubMed ID: 31429532
[TBL] [Abstract][Full Text] [Related]
4. Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012.
Cheung MY; Ho AW; Wong SH
Hong Kong Med J; 2018 Dec; 24(6):579-583. PubMed ID: 30449735
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of anti-osteoporosis treatment after hip fracture.
Rabenda V; Vanoverloop J; Fabri V; Mertens R; Sumkay F; Vannecke C; Deswaef A; Verpooten GA; Reginster JY
J Bone Joint Surg Am; 2008 Oct; 90(10):2142-8. PubMed ID: 18829912
[TBL] [Abstract][Full Text] [Related]
6. Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
Shah A; Prieto-Alhambra D; Hawley S; Delmestri A; Lippett J; Cooper C; Judge A; Javaid MK;
Osteoporos Int; 2017 Jan; 28(1):169-178. PubMed ID: 27812809
[TBL] [Abstract][Full Text] [Related]
7. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.
Jennings LA; Auerbach AD; Maselli J; Pekow PS; Lindenauer PK; Lee SJ
J Am Geriatr Soc; 2010 Apr; 58(4):650-7. PubMed ID: 20398147
[TBL] [Abstract][Full Text] [Related]
8. Prescription practices of anti-osteoporosis medication among Thai orthopedic surgeons (PAMOS study) in osteoporotic hip fracture.
Kittithamvongs P; Pongpirul K
Arch Osteoporos; 2019 Jun; 14(1):62. PubMed ID: 31214879
[TBL] [Abstract][Full Text] [Related]
9. Undertreatment of osteoporosis following hip fracture: a retrospective, observational study in Singapore.
Chau YT; Nashi N; Law LS; Goh RKH; Choo SX; Seetharaman SK
Arch Osteoporos; 2020 Sep; 15(1):141. PubMed ID: 32918196
[TBL] [Abstract][Full Text] [Related]
10. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
[TBL] [Abstract][Full Text] [Related]
11. A survey of outcomes and management of patients post fragility fractures in China.
Wang O; Hu Y; Gong S; Xue Q; Deng Z; Wang L; Liu H; Tang H; Guo X; Chen J; Jia X; Xu Y; Lan L; Lei C; Dong H; Yuan G; Fu Q; Wei Y; Xia W; Xu L
Osteoporos Int; 2015 Nov; 26(11):2631-40. PubMed ID: 25966892
[TBL] [Abstract][Full Text] [Related]
12. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study.
Kim SC; Kim MS; Sanfélix-Gimeno G; Song HJ; Liu J; Hurtado I; Peiró S; Lee J; Choi NK; Park BJ; Avorn J
Am J Med; 2015 May; 128(5):519-26.e1. PubMed ID: 25660252
[TBL] [Abstract][Full Text] [Related]
13. Treatment and Management of Osteoporotic Fractures: A Nation-wide Survey of 484 Senior Orthopaedists in China.
Man Y; Pan W; Lu J; Li SY; Zhang P; Guo JZ; Yu SF; Zhang B; Xiao E; Zhang C; Zuo W; Jin HJ; Chen Y; Wu B; Shi XE; Hong D; Liu X; Gao YX; Li J; Yin L; Xue QY
Orthop Surg; 2016 Nov; 8(4):432-439. PubMed ID: 28032704
[TBL] [Abstract][Full Text] [Related]
14. Screening and treatment of osteoporosis after hip fracture: comparison of sex and race.
Antonelli M; Einstadter D; Magrey M
J Clin Densitom; 2014; 17(4):479-83. PubMed ID: 24657109
[TBL] [Abstract][Full Text] [Related]
15. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
Kristensen PK; Ehrenstein V; Shetty N; Pedersen AB
Osteoporos Int; 2019 Sep; 30(9):1817-1825. PubMed ID: 31263921
[TBL] [Abstract][Full Text] [Related]
16. [Primary and Secondary Prevention of Hip Fragility Fracture in Teruel Health Sector, Aragon, Spain].
Gómez Navarro R; González García P; Martín Hernández C; Castro Sauras Á; Valdearcos Enguídanos S
Rev Esp Salud Publica; 2017 Jan; 91():. PubMed ID: 28025971
[TBL] [Abstract][Full Text] [Related]
17. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
Klop C; Gibson-Smith D; Elders PJ; Welsing PM; Leufkens HG; Harvey NC; Bijlsma JW; van Staa TP; de Vries F
Osteoporos Int; 2015 Jul; 26(7):1919-28. PubMed ID: 25963232
[TBL] [Abstract][Full Text] [Related]
18. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.
Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K
Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493
[TBL] [Abstract][Full Text] [Related]
19. Antiresorptive treatment, when initiated after a first hip fracture, may not protect of a second contralateral episode in elderly population: A study with 685 patients.
Besalduch M; Carrera I; Gómez-Masdeu M; De Caso J
Injury; 2016 Apr; 47(4):877-80. PubMed ID: 26892501
[TBL] [Abstract][Full Text] [Related]
20. Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture.
Follin SL; Black JN; McDermott MT
Pharmacotherapy; 2003 Feb; 23(2):190-8. PubMed ID: 12587808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]